Please Wait...

DIA's 21st Annual Workshop in Japan for Clinical Data Management

February 19, 2018 - 1:00am (EST) to February 20, 2018 - 1:00am (EST)

Join Bioclinica’s Chief Commercial Officer David Kiger at DIA Japan in Tokyo where he will present a special topic on February 20 at 16:30 in Session 6: Data Management in Investigator-Initiated Clinical Trials and Clinical Research.

 

Session Co-Chairs:

Akimitsu Ikeura, Manager, Data Management Group, Biostatistics & Data Management Dept., Daiichi Sankyo Co., Ltd.

Kyoko Minamoto, Clinical Data Manager, Clinical Research Support Center, The University of Tokyo Hospital

After the Pharmaceutical Affairs Law was revised in 2003, investigators and pharmaceutical companies could plan and conduct clinical trials themselves. In the 15 years since passed, compliance with CDISC and other international standards has become indispensable, and individual investigators have increasingly needed to secure funds and other resources from external sources. It is now expected that academic clinical research will be effected by the new Act on Clinical Studies published in April 2017. This session will discuss anticipated developments impacting investigator-initiated clinical trials in academia.

Unstructured and Structured Big Data Convergence for Bridging Clinical, Regulatory, and Commercialization

David Kiger, Chief Commercial Officer, Bioclinica

Data Management in Pharmaceutical industry and Academia (tentative)

Mikio Mori, Section Head, Data Management Section, Data Management Division, Clinical Research Support Office, National Cancer Center Hospital

New Act on Clinical Studies (tentative)

Yasuhiro Fujiwara, MD, PhD, Director General, Strategic Planning Bureau, National Cancer Center

 

Visit Event Website

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

On the hunt for agile IRT? Ask these 5 Qs to see if it's the real thing. DISCLOSURE: We happen to have such an offe… https://t.co/S6507WxBC8
bioclinica (21 hours ago)
Be among the 1st to hear findings presented in 6 scientific posters in which experts @bioclinica in #Alzheimers… https://t.co/4mBEtFiX0a
bioclinica (3 days ago)
Still using manual methods for trial budget management and forecasting ? A Bioclinica whitepaper shows how purpose-… https://t.co/WlrHLk9B0z
bioclinica (3 days ago)
Swing by @Bioclinica to discuss global site network partnering opportunities during @MySCRS Asia-Pac Site Solutions… https://t.co/m8GHxSmPMY
bioclinica (4 days ago)
Hello from Clinical Operations in Oncology Trials East Coast where Bioclinica is exhibiting & presenting a case stu… https://t.co/oTKJAVddH4
bioclinica (2 weeks ago)
Challenge overcome! Course-correct a clinical trial & collect 400 time points from 40 sites across the US & EU -- a… https://t.co/n3TLrjW3xi
bioclinica (2 weeks ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen